Published in J Virol on October 01, 1996
Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol (2000) 2.07
Maternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring. Am J Epidemiol (2016) 1.08
No link between viral findings in the prostate and subsequent cancer development. Br J Cancer (2006) 1.05
Illumination of murine gammaherpesvirus-68 cycle reveals a sexual transmission route from females to males in laboratory mice. PLoS Pathog (2013) 0.94
Human viruses and cancer. Viruses (2014) 0.92
Plasmodium falciparum infection is associated with Epstein-Barr virus reactivation in pregnant women living in malaria holoendemic area of Western Kenya. Matern Child Health J (2015) 0.83
Seminal shedding of human herpesviruses. Virol J (2013) 0.80
Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection. J Infect Dis (2016) 0.75
Identification of Epstein-Barr Virus in the Human Placenta and Its Pathologic Characteristics. J Korean Med Sci (2017) 0.75
Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature (1978) 3.73
A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell (1995) 3.17
Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Int J Cancer (1972) 2.80
Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer (1977) 2.66
Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol (1971) 2.40
Cytomegalovirus infection in pregnancy: preliminary findings from a prospective study. Lancet (1983) 2.18
Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet (1990) 1.64
A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet (1986) 1.61
Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med (1985) 1.47
Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer (1978) 1.43
Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. J Clin Microbiol (1995) 1.34
Intrauterine infection with herpes simplex virus. Resultant congenital malformations. JAMA (1973) 1.28
The Epstein-Barr virus as a model of virus-host interactions. Br Med Bull (1985) 1.24
Recovery of Epstein-Barr virus from genital ulcers. N Engl J Med (1984) 1.19
Varicella-zoster infections in pregnancy. JAMA (1967) 1.08
Is Burkitt's lymphoma related to perinatal infection by Epstein-Barr virus? Lancet (1977) 1.06
Herpesvirus infections of pregnancy. Part II: Herpes simplex virus and varicella-zoster virus infections. N Engl J Med (1985) 1.04
A prospective study of cytomegalovirus infection in pregnancy. I. Laboratory evidence of congenital infection following maternal primary and reactivated infection. J Infect (1981) 1.03
Search for maternal cells in human umbilical cord blood by polymerase chain reaction amplification of two minisatellite sequences. Blood (1994) 0.97
Leukocyte transforming agent (Epstein-Barr virus) in newborn infants and older individuals. J Pediatr (1976) 0.96
Simultaneous congenital infection with Epstein-Barr virus and cytomegalovirus. N Engl J Med (1981) 0.93
Epstein-Barr virus infection in the neonatal period and in childhood. Can Med Assoc J (1974) 0.92
Spontaneous in vitro transformation of leukocytes from a neonate. Proc Soc Exp Biol Med (1973) 0.92
Subclinical Epstein-Barr virus infection of both the male and female genital tract--indication for sexual transmission. J Invest Dermatol (1992) 0.91
Epstein-Barr virus infection in HIV-positive patients. Eur J Clin Microbiol Infect Dis (1993) 0.91
Prevalence of Epstein-Barr virus in the cervix. J Clin Pathol (1994) 0.90
Detection of active Epstein-Barr infection in pregnant women. Eur J Clin Microbiol (1985) 0.90
Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus. J Clin Microbiol (1991) 0.89
PARTURITION VARICELLA-ZOSTER. Obstet Gynecol (1964) 0.88
Detection of anti-Epstein-Barr virus trans-activator (ZEBRA) antibodies in sera from patients with human immunodeficiency virus. J Infect Dis (1991) 0.86
Prospective study of Epstein Barr virus (EBV) infection during pregnancy. Biomedicine (1981) 0.86
Epstein-Barr virus infections in pregnancy: a prospective study. J Pediatr (1984) 0.86
Epstein--Barr virus infection: seroepidemiology in various population groups of the greater Montreal area. Comp Immunol Microbiol Infect Dis (1979) 0.81
In utero Epstein-Barr virus (infectious mononucleosis) infection. JAMA (1981) 0.81
Epstein-Barr virus infections during pregnancy. A prospective study and review of the literature. Am J Dis Child (1983) 0.80
Persistent Epstein-Barr virus infection and pregnancy. J Infect Dis (1983) 0.80
Infections due to Epstein-Barr virus during pregnancy. J Infect Dis (1981) 0.80
[Congenital Epstein-Barr virus infection]. Monatsschr Kinderheilkd (1993) 0.79
Enzyme-linked immunosorbent assay for antibodies to ZEBRA, an Epstein-Barr trans-activator. Res Virol (1994) 0.79
Infectious mononucleosis and congenital anomalies. Am J Obstet Gynecol (1978) 0.78
Epstein-Barr virus transactivator antibodies in HIV infection. Lancet (1991) 0.77
Seroepidemiology of Epstein-Barr virus in pregnant women. J Infect Dis (1982) 0.77
Infectious mononucleosis. Age, civil state and pregnancy--an epidemiological study. Scand J Infect Dis (1969) 0.77
Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med (1996) 7.08
Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J Virol (1998) 3.21
The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol Cell Biol (1994) 3.16
Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J Virol (1995) 3.04
Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology (1984) 2.48
Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J Virol (1999) 2.40
Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J Virol (2001) 2.25
Homo-FRET microscopy in living cells to measure monomer-dimer transition of GFP-tagged proteins. Biophys J (2001) 2.07
Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J Clin Microbiol (2001) 1.97
Monoclonal antibodies against respiratory syncytial virus and their use for rapid detection of virus in nasopharyngeal secretions. J Clin Microbiol (1985) 1.96
Mdm2: keeping p53 under control. Oncogene (1997) 1.83
Quantification of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol (2001) 1.82
Isolation of a human pararotavirus. Virology (1983) 1.73
Quantification of enterovirus RNA in sludge samples using single tube real-time RT-PCR. Biotechniques (2000) 1.67
Identification of Epstein-Barr virus sequences that encode a nuclear antigen expressed in latently infected lymphocytes. Proc Natl Acad Sci U S A (1984) 1.66
Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector. J Virol (1987) 1.61
Nucleotide sequence of SHV-2 beta-lactamase gene. Antimicrob Agents Chemother (1990) 1.61
Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay. J Clin Microbiol (2000) 1.60
Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required. Nucleic Acids Res (1991) 1.53
Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. J Virol (1995) 1.49
Toxoplasma colitis in the acquired immunodeficiency syndrome. Am J Gastroenterol (1992) 1.46
Occurrence of acute hepatitis A in patients infected with human immunodeficiency virus. Clin Infect Dis (2000) 1.45
Treatment of antibiotic-induced colitis by metronidazole. Lancet (1978) 1.40
[Preimplantation diagnosis of delta F508 mutation of mucoviscidosis in transgenic mice]. Presse Med (1995) 1.38
Clinical and echocardiographic observations in pulmonary valve endocarditis. Am J Cardiol (1985) 1.33
Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett (1998) 1.31
Use of the arbitrary primer polymerase chain reaction for investigating an outbreak of Clostridium difficile-associated diarrhea in AIDS patients. Eur J Clin Microbiol Infect Dis (1993) 1.30
Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor. Mol Cell Endocrinol (1997) 1.27
A one-year virological survey of acute intussusception in childhood. J Med Virol (1982) 1.24
Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis (1995) 1.20
Phylogenetic analyses indicate an atypical nurse-to-patient transmission of human immunodeficiency virus type 1. J Virol (2000) 1.19
The DNA-binding domain of two bZIP transcription factors, the Epstein-Barr virus switch gene product EB1 and Jun, is a bipartite nuclear targeting sequence. J Virol (1993) 1.18
A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules. Biotechniques (1990) 1.17
Specific recognition of androgens by their nuclear receptor. A structure-function study. J Biol Chem (2000) 1.16
Host range temperature-conditional mutants in the adenovirus DNA binding protein are defective in the assembly of infectious virus. Virology (1983) 1.16
Transformation by adenovirus early region 2A temperature-sensitive mutants and their revertants. Virology (1981) 1.13
Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int J Cancer (1991) 1.11
Investigation of a nosocomial outbreak of Clostridium difficile-associated diarrhoea among AIDS patients by random amplified polymorphic DNA (RAPD) assay. J Hosp Infect (1994) 1.02
Affinity chromatography: large-scale purification of the soluble oestradiol-17- dehydrogenase of human placenta. FEBS Lett (1972) 1.01
Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR. J Med Virol (2001) 1.01
Reporter cell lines to study the estrogenic effects of xenoestrogens. Sci Total Environ (1999) 1.00
Mutant carrying deletions in the two simian virus 40 early genes. J Virol (1981) 1.00
Internalization of alpha 2 macroglobulin in receptosomes. Studies with monovalent electron microscopic markers. Exp Cell Res (1981) 0.99
Structure and function of DNA binding proteins from revertants of adenovirus type 5 mutants with a temperature-sensitive DNA replication. Virology (1983) 0.98
[Pathophysiological mechanisms of dengue fever: critical review of current concepts]. Med Trop (Mars) (2009) 0.98
Study of genetic reassortment between two human rotaviruses. Virology (1984) 0.97
Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP. Biochemistry (2001) 0.97
Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.96
Characterization of a plasmid coding for resistance to broad-spectrum cephalosporins in Salmonella typhimurium. Drugs Exp Clin Res (1989) 0.96
Involvement of the SREBP pathway in the mode of action of androgens in sebaceous glands in vivo. Exp Dermatol (2003) 0.96
Reporter cell lines are useful tools for monitoring biological activity of nuclear receptor ligands. Luminescence (2001) 0.95
Survey of human rotavirus propagation as studied by electrophoresis of genomic RNA. J Infect Dis (1984) 0.95
Epidemiologic and genomic study of rotavirus strains infecting young children and calves in the same rural environment. Eur J Epidemiol (1986) 0.94
Serological characterization of human reassortant rotaviruses. J Virol (1986) 0.94
Provirus copy number to predict disease progression in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis (1994) 0.93
Analysis of the spontaneous in vitro anti-HIV-1 antibody secretion by peripheral blood mononuclear cells in HIV-1 infection. Clin Exp Immunol (1991) 0.93
Detection of human Betaherpesvirinae in saliva and urine from immunocompromised and immunocompetent subjects. J Clin Microbiol (1997) 0.92
Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients. J Infect (1999) 0.91
Antibody response to the rubella virus structural proteins in infants with the congenital rubella syndrome. J Med Virol (1986) 0.90
Cytomegalovirus-specific B cell activation as a potential marker for the diagnosis of cytomegalovirus infection. Eur J Clin Microbiol Infect Dis (1990) 0.90
Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines. Endocr Relat Cancer (2005) 0.90
Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res (1994) 0.90
Mutation of isoleucine 747 by a threonine alters the ligand responsiveness of the human glucocorticoid receptor. Mol Endocrinol (1996) 0.89
Conservation of structural domains and biochemical activities of the MDM2 protein from Xenopus laevis. Oncogene (1997) 0.89
Disorders linked to insufficient androgen action in male children. Hum Reprod Update (2001) 0.87
Continuous systemic secretion of a lysosomal enzyme by genetically modified mouse skin fibroblasts. Transplantation (1993) 0.87
Cyclic AMP-dependent phosphorylation in intact cells and in cell-free extracts from Chinese hamster ovary cells. Studies with wild type and cyclic AMP-resistant mutants. J Biol Chem (1981) 0.87
[Listeriosis in obstetrical environment. Report on 10-year experience in a maternity hospital in Paris]. J Gynecol Obstet Biol Reprod (Paris) (1986) 0.87
Engineered cell lines as a tool for monitoring biological activity of hormone analogs. Anal Biochem (1997) 0.86
A mutation in the adenovirus type 5 DNA binding protein that fails to autoregulate the production of the DNA binding protein. Virology (1982) 0.86
Estrogenic activity of cosmetic components in reporter cell lines: parabens, UV screens, and musks. J Toxicol Environ Health A (2005) 0.86
Detection of anti-Epstein-Barr virus trans-activator (ZEBRA) antibodies in sera from patients with human immunodeficiency virus. J Infect Dis (1991) 0.86
Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.86
Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion. J Infect Dis (1996) 0.86
Some new developments in the knowledge of human placental estradiol-17beta dehydrogenase. J Steroid Biochem (1977) 0.85
[Aortic and mitral endocarditis caused by Haemophilus paraphrophilus with abscess of the aortic ring and cerebral embolism]. Arch Mal Coeur Vaiss (1989) 0.85
Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling. Cancer Res (2000) 0.85
Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection. AIDS (2001) 0.85
In vitro and in vivo interactions between nuclear receptors at estrogen response elements. J Steroid Biochem Mol Biol (1996) 0.84
[Erysipelothrix rhusiopathiae endocarditis. A case report and review of the literature]. Ann Med Interne (Paris) (1983) 0.84
Epidemiological and clinical study and electrophoretyping survey of rotavirus acute diarrhoea in a children's infectious disease unit in Casablanca, Morocco. Ann Inst Pasteur Virol (1989) 0.84
Two cases of cytomegalovirus infection revealed by hearing loss in HIV-infected patients. Biomed Pharmacother (1997) 0.84
High expression of MDM2 protein and low rate of p21(WAF1/CIP1) expression in SCID mice Epstein Barr virus-induced lymphoproliferation. J Histochem Cytochem (1999) 0.84
Production of HIV-1 by human B cells infected in vitro: characterization of an EBV genome-negative B cell line chronically synthetizing a low level of HIV-1 after infection. Virology (1998) 0.84
A cell surface marker gene transferred with a retroviral vector into CD34+ cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus. Blood (1996) 0.84
Detection of single base substitutions in polynucleotides by capture with immobilized oligonucleotides. Mol Cell Probes (1993) 0.83
Follow-up of subjects with isolated and persistent anti-core (anti-p24 or anti-p17) antibodies to HIV. AIDS (1988) 0.83
Enzymatic determination of estradiol and estrone in plasma and urine. Clin Chim Acta (1979) 0.83
Simplified enzyme-linked immunosorbent assay for specific antibodies to respiratory syncytial virus. J Clin Microbiol (1986) 0.83
Female sex steroid receptors in postmenopausal endometrial carcinoma and biochemical response to an antiestrogen. Cancer Res (1981) 0.83
Exploration of the cellular mediated immunity by the blastogenesis test during chronic brucellosis in human. Comp Immunol Microbiol Infect Dis (1987) 0.83
Temperature-independent revertants of adenovirus H5ts125 and H5ts107 mutants in the DNA binding protein: isolation of a new class of host range temperature conditional revertants. Virology (1981) 0.82
[Indigenous Legionnaires' disease. Importance of clinical symptoms (author's transl)]. Nouv Presse Med (1980) 0.82
[Chemiluminescence and bioluminescence in clinical analysis. Perspectives of development]. Ann Biol Clin (Paris) (1985) 0.82
Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment. AIDS Res Hum Retroviruses (2001) 0.82
Unsuccessful treatment of Legionella pneumophila infection with a fluoroquinolone. Clin Infect Dis (1993) 0.82
Variations of urinary Tamm-Horsfall protein in humans during the first thirty years of life. Nephron (1984) 0.82